Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 4
1 (50.0%)An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
Phase 4
- Conditions
- Embolic Stroke of Undetermined SourceAtrial Fibrillation
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Sigknow Biomedical Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT05089435
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
Not Applicable
- Conditions
- Atrial FibrillationArrhythmias, Cardiac
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- Sigknow Biomedical Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03602742
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taiwan, Taipei, Taiwan
🇨🇳Chang Gung Medical Foundation, Linkou, Taoyuan, Taiwan
News
No news found